Table 1 Clinical and demographical characteristics of renal allograft recipients (n = 211) prior to transplantation
Age in years, median (range) | 57 (19–79) |
|---|---|
Male/female | 62–38% |
Follow-up time in months, median (range) | 74 (0–97) |
Living kidney donor, n (%) | 211 (100%) |
Previous kidney transplant, n (%) | 19 (9.0%) |
Pre-emptive transplantation, n (%) | 91 (43.1%) |
Anti-rejection therapy | 39 (18.4%) |
T cell depleting therapy for rejection | 18 (8.5%) |
Cardiovascular disease prior to transplantation, n (%) | 53 (25.1%) |
Distribution of underlying kidney disease | |
Nephrosclerosis/hypertension | 22.7% |
Primary glomerulopathies | 13.7% |
Diabetes mellitus | 19.9% |
Urinary tract infections/ stones | 2.8% |
Reflux nephropathy | 4.7% |
Polycystic kidney disease | 19.0% |
Other | 11.8% |
Unknown | 5.2% |
CMV seropositive* | 59% |
Recipients deceased during follow-up | 30 |
Cause of death | |
cardiovascular disease | 20.0% |
infection | 26.7% |
cancer | 26.7% |
other | 3.3% |
unknown | 23.3% |